Androgen resistance--the clinical and molecular spectrum.

RESISTANCE to the action of androgens, like other forms of hormone resistance, is characterized by partial or complete absence of the usual effects of the hormones and normal or increased hormone production.1 Since androgens are important for normal male sexual development and fertility, defects in androgen action are often associated with abnormal sexual differentiation, infertility, or both. This article reviews the phenotypic variation and the range of molecular defects that have been identified in persons with mutations causing androgen resistance. Male Phenotypic Development During embryogenesis the indifferent gonad in males is converted to a testis in response to a testis-determining . . .

[1]  P. Riegman,et al.  The promoter of the prostate-specific antigen gene contains a functional androgen responsive element. , 1991, Molecular endocrinology.

[2]  D. Russell,et al.  Deletion of steroid 5α-reductase 2 gene in male pseudohermaphroditism , 1991, Nature.

[3]  J. Wilson,et al.  Androgen resistance associated with a mutation of the androgen receptor at amino acid 772 (Arg----Cys) results from a combination of decreased messenger ribonucleic acid levels and impairment of receptor function. , 1991, The Journal of clinical endocrinology and metabolism.

[4]  J. Wilson,et al.  Molecular basis of androgen resistance in a family with a qualitative abnormality of the androgen receptor and responsive to high-dose androgen therapy. , 1991, The Journal of clinical investigation.

[5]  J. Wilson,et al.  A mutation in the DNA-binding domain of the androgen receptor gene causes complete testicular feminization in a patient with receptor-positive androgen resistance. , 1991, The Journal of clinical investigation.

[6]  F. S. French,et al.  Functional characterization of naturally occurring mutant androgen receptors from subjects with complete androgen insensitivity. , 1990, Molecular endocrinology.

[7]  J. Trapman,et al.  Aberrant splicing of androgen receptor mRNA results in synthesis of a nonfunctional receptor protein in a patient with androgen insensitivity. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[8]  C. Wilson,et al.  Definition of the human androgen receptor gene structure permits the identification of mutations that cause androgen resistance: premature termination of the receptor protein at amino acid residue 588 causes complete androgen resistance. , 1990, Molecular endocrinology.

[9]  Robin Lovell-Badge,et al.  A gene from the human sex-determining region encodes a protein with homology to a conserved DNA-binding motif , 1990, Nature.

[10]  S. Seino,et al.  An exonic point mutation of the androgen receptor gene in a family with complete androgen insensitivity. , 1990, American journal of human genetics.

[11]  F. S. French,et al.  A single base mutation in the androgen receptor gene causes androgen insensitivity in the testicular feminized rat. , 1990, The Journal of biological chemistry.

[12]  C. Wilson,et al.  A single nucleotide substitution introduces a premature termination codon into the androgen receptor gene of a patient with receptor-negative androgen resistance. , 1990, Journal of Clinical Investigation.

[13]  D. Russell,et al.  Structural and biochemical properties of cloned and expressed human and rat steroid 5 alpha-reductases. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[14]  B. O’Malley.  The steroid receptor superfamily: more excitement predicted for the future. , 1990, Molecular endocrinology.

[15]  J. Wilson,et al.  Testosterone at high concentrations interacts with the human androgen receptor similarly to dihydrotestosterone. , 1990, Endocrinology.

[16]  F. S. French,et al.  Sequence of the intron/exon junctions of the coding region of the human androgen receptor gene and identification of a point mutation in a family with complete androgen insensitivity , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[17]  L. Johnson,et al.  The Effect of a 5α-Reductase Inhibitor on Androgen Physiology in the Immature Male Rat* , 1989 .

[18]  J. Wilson,et al.  Androgen resistance associated with a qualitative abnormality of the androgen receptor and responsive to high dose androgen therapy. , 1989, The Journal of clinical endocrinology and metabolism.

[19]  F. S. French,et al.  Deletion of the steroid-binding domain of the human androgen receptor gene in one family with complete androgen insensitivity syndrome: evidence for further genetic heterogeneity in this syndrome. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[20]  J. A. van der Korput,et al.  Cloning, structure and expression of a cDNA encoding the human androgen receptor. , 1988, Biochemical and biophysical research communications.

[21]  Chawnshang Chang,et al.  Molecular cloning of human and rat complementary DNA encoding androgen receptors. , 1988, Science.

[22]  H. Willard,et al.  Cloning of human androgen receptor complementary DNA and localization to the X chromosome. , 1988, Science.

[23]  J. Wilson,et al.  A mutation of the androgen receptor associated with partial androgen resistance, familial gynecomastia, and fertility. , 1988, The Journal of clinical endocrinology and metabolism.

[24]  H. Burger,et al.  Variable androgen receptor levels in infertile men. , 1987, The Journal of clinical endocrinology and metabolism.

[25]  L. Johnson,et al.  Characterization of the Testicular Abnormality in 5a-Reductase Deficiency , 1986 .

[26]  J. Wilson,et al.  High dose androgen therapy in male pseudohermaphroditism due to 5 alpha-reductase deficiency and disorders of the androgen receptor. , 1984, The Journal of clinical investigation.

[27]  J. Wilson,et al.  Transformation of human androgen receptors to the deoxyribonucleic acid-binding state. , 1983, Endocrinology.

[28]  J. Griffin,et al.  Qualitative receptor defects in families with androgen resistance: failure of stabilization of the fibroblast cytosol androgen receptor. , 1982, The Journal of clinical endocrinology and metabolism.

[29]  C. Migeon,et al.  Human complete androgen insensitivity with normal dihydrotestosterone receptor binding capacity in cultured genital skin fibroblasts: evidence for a qualitative abnormality of the receptor. , 1982, The Journal of clinical endocrinology and metabolism.

[30]  J. Griffin,et al.  The frequency of androgen receptor deficiency in infertile men. , 1982, The Journal of clinical endocrinology and metabolism.

[31]  J. Wilson,et al.  Origin of estrogen in normal men and in women with testicular feminization. , 1979, The Journal of clinical endocrinology and metabolism.

[32]  R. E. Peterson,et al.  Androgens and the evolution of male-gender identity among male pseudohermaphrodites with 5alpha-reductase deficiency. , 1979, The New England journal of medicine.

[33]  Ronald J. Moore,et al.  Regulation of cytoplasmic dihydrotestosterone binding in dog prostate by 17 beta-estradiol. , 1979, The Journal of clinical investigation.

[34]  P. Walsh.  A new cause of male infertility. , 1979, The New England journal of medicine.

[35]  J. D. Wilson,et al.  Androgen insensitivity as a cause of infertility in otherwise normal men. , 1979, The New England journal of medicine.

[36]  J. Griffin,et al.  Studies of gonadotropin-gonadal dynamics in patients with androgen insensitivity. , 1978, The Journal of clinical endocrinology and metabolism.

[37]  J. Griffin,et al.  Hereditary Male Pseudohermaphroditism Associated with an Unstable Form of 5α-Reductase , 1978 .

[38]  R. E. Peterson,et al.  MALE PSEUDOHERMAPHRODITISM DUE TO STEROID 5α-REDUCTASE DEFICIENCY , 1977 .

[39]  C. Migeon,et al.  Androgen insensitivity in man: evidence for genetic heterogeneity. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[40]  P. Walsh,et al.  Clinical and endocrinologic characterization of a patients with the syndrome of incomplete testicular feminization. , 1975, The Journal of clinical endocrinology and metabolism.

[41]  J. D. Wilson,et al.  Familial incomplete male pseudohermaphroditism, type 2. Decreased dihydrotestosterone formation in pseudovaginal perineoscrotal hypospadias. , 1974, The New England journal of medicine.

[42]  C. Migeon,et al.  Syndrome of androgen insensitivity in man: absence of 5 alpha-dihydrotestosterone binding protein in skin fibroblasts. , 1974, The Journal of clinical endocrinology and metabolism.

[43]  J. D. Wilson,et al.  Familial incomplete male pseudohermaphroditism, type 1. Evidence for androgen resistance and variable clinical manifestations in a family with the Reifenstein syndrome. , 1974, The New England journal of medicine.

[44]  J. Wilson,et al.  Developmental pattern of testosterone synthesis in the fetal gonad of the rabbit. , 1973, Endocrinology.

[45]  J. Morris,et al.  The syndrome of testicular feminization in male pseudohermaphrodites. , 1953, American journal of obstetrics and gynecology.

[46]  J. Wilson,et al.  Characterization and expression of a cDNA encoding the human androgen receptor. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[47]  P. Donahoe,et al.  Müllerian inhibiting substance: gene structure and mechanism of action of a fetal regressor. , 1987, Recent progress in hormone research.

[48]  J. Wilson,et al.  Characterization of the cytosol androgen receptor of the human prostate. , 1983, The Journal of clinical endocrinology and metabolism.

[49]  J. Wilson,et al.  Testosterone formation and metabolism during male sexual differentiation in the human embryo. , 1974, The Journal of clinical endocrinology and metabolism.

[50]  W. Lenz,et al.  Genetic aspects in male hypogonadism. , 1961, Recent progress in hormone research.